[go: up one dir, main page]

DK1017675T3 - Stærkt lipofile camptothecinderivater - Google Patents

Stærkt lipofile camptothecinderivater

Info

Publication number
DK1017675T3
DK1017675T3 DK98904990T DK98904990T DK1017675T3 DK 1017675 T3 DK1017675 T3 DK 1017675T3 DK 98904990 T DK98904990 T DK 98904990T DK 98904990 T DK98904990 T DK 98904990T DK 1017675 T3 DK1017675 T3 DK 1017675T3
Authority
DK
Denmark
Prior art keywords
derivatives
camptothecin derivatives
strongly lipophilic
lipophilic camptothecin
substitution
Prior art date
Application number
DK98904990T
Other languages
English (en)
Inventor
Frederick H Hausheer
Kochat Haridas
Dasharatha G Reddy
Shijie Yao
Dhanabalan Murali
P Seetharamulu
Pavankumar N V Petluru
Original Assignee
Bionumerik Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionumerik Pharmaceuticals Inc filed Critical Bionumerik Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1017675T3 publication Critical patent/DK1017675T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Silicon Polymers (AREA)
DK98904990T 1997-02-14 1998-02-11 Stærkt lipofile camptothecinderivater DK1017675T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3714897P 1997-02-14 1997-02-14

Publications (1)

Publication Number Publication Date
DK1017675T3 true DK1017675T3 (da) 2006-10-16

Family

ID=21892705

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98904990T DK1017675T3 (da) 1997-02-14 1998-02-11 Stærkt lipofile camptothecinderivater

Country Status (10)

Country Link
EP (1) EP1017675B1 (da)
JP (2) JP4311765B2 (da)
AT (1) ATE329903T1 (da)
AU (1) AU6272598A (da)
CA (1) CA2280905C (da)
DE (1) DE69834923T2 (da)
DK (1) DK1017675T3 (da)
ES (1) ES2262223T3 (da)
PT (1) PT1017675E (da)
WO (1) WO1998035940A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150343A (en) * 1993-06-30 2000-11-21 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US6136978A (en) * 1993-06-30 2000-10-24 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US6743917B2 (en) 1993-06-30 2004-06-01 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
FR2790261B1 (fr) 1999-02-26 2004-09-10 Sod Conseils Rech Applic Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation
DK1017675T3 (da) * 1997-02-14 2006-10-16 Bionumerik Pharmaceuticals Inc Stærkt lipofile camptothecinderivater
US6057303A (en) * 1998-10-20 2000-05-02 Bionumerik Pharmaceuticals, Inc. Highly lipophilic Camptothecin derivatives
US6207832B1 (en) * 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
AU4822500A (en) * 1999-05-04 2000-11-17 Bionumerik Pharmaceuticals, Inc. Novel highly lipophilic camptothecin analogs
US6350756B1 (en) 2001-01-18 2002-02-26 California Pacific Medical Center Camptothecin derivatives
US6855720B2 (en) 2001-03-01 2005-02-15 California Pacific Medical Center Nitrogen-based camptothecin derivatives
US6372906B1 (en) 2001-04-12 2002-04-16 University Of Pittsburgh Synthesis of silyl camptothecins and silyl homocamptothecins
US6723853B2 (en) 2001-08-27 2004-04-20 University Of Pittsburgh Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins
AU2002356720B2 (en) 2001-11-30 2009-01-29 Chugai Seiyaku Kabushiki Kaisha Hexacyclic compounds
AU2003243380A1 (en) 2002-06-03 2003-12-19 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
EP1393719A1 (en) * 2002-08-23 2004-03-03 Munich Biotech AG Camptothecin-carboxylate formulations
US7067666B2 (en) * 2003-06-27 2006-06-27 Research Triangle Institute 7-substituted camptothecin and camptothecin analogs and methods for producing the same
JP5654723B2 (ja) * 2003-12-17 2015-01-14 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド カンプトテシン医薬処方物およびその製法
BRPI0509732A (pt) 2004-04-09 2007-09-25 Chugai Pharmaceutical Co Ltd pró-fármaco solúvel em água, composição farmacêutica, agente terapêutico, agente antifungo e uso do referido pró-fármaco
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
US7875602B2 (en) 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
WO2007075492A1 (en) * 2005-12-16 2007-07-05 Sonus Pharmaceuticals, Inc. Lipophilic anticancer drug compounds
JP2010500350A (ja) * 2006-08-11 2010-01-07 ザ クリストゥス ステーリン ファウンデーション フォー キャンサー リサーチ カンプトテシンのエステルの製造法
CN103068404B (zh) 2010-06-11 2015-11-25 独立行政法人科学技术振兴机构 药物多聚物微粒及其制造方法
US9556192B2 (en) 2012-10-30 2017-01-31 Nerviano Medical Sciences S.R.L. Functionalized 9-bromo-camptothecin derivatives
FR3029637B1 (fr) 2014-12-05 2018-01-05 Universite De Strasbourg Microdispositif de detection de composes organiques volatils et methode de detection d'au moins un compose organique volatil compris dans un echantillon gazeux
WO2025077767A1 (zh) * 2023-10-10 2025-04-17 上海翊维康医药有限责任公司 新的i型拓扑异构酶抑制剂及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
US5446047A (en) * 1992-07-23 1995-08-29 Sloan-Kettering Institute For Cancer Research Camptothecin analogues
US5468754A (en) * 1994-04-19 1995-11-21 Bionumerik Pharmaceuticals, Inc. 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
GB9510716D0 (en) * 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
DK1017675T3 (da) * 1997-02-14 2006-10-16 Bionumerik Pharmaceuticals Inc Stærkt lipofile camptothecinderivater

Also Published As

Publication number Publication date
JP5264561B2 (ja) 2013-08-14
JP4311765B2 (ja) 2009-08-12
WO1998035940A1 (en) 1998-08-20
DE69834923D1 (en) 2006-07-27
CA2280905C (en) 2006-08-29
EP1017675A4 (en) 2001-08-22
CA2280905A1 (en) 1998-08-20
EP1017675A1 (en) 2000-07-12
ATE329903T1 (de) 2006-07-15
JP2001511807A (ja) 2001-08-14
ES2262223T3 (es) 2006-11-16
PT1017675E (pt) 2006-09-29
AU6272598A (en) 1998-09-08
EP1017675B1 (en) 2006-06-14
JP2009149680A (ja) 2009-07-09
DE69834923T2 (de) 2006-10-19

Similar Documents

Publication Publication Date Title
DK1017675T3 (da) Stærkt lipofile camptothecinderivater
ATE261974T1 (de) Hoch-lipophile campothecin-derivate
EA200100111A1 (ru) Ингибиторы фарнезилпротеинтрансферазы, обладающие in vivo радиосенсибилизирующими свойствами
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
AR022860A1 (es) Derivados de camptotecina que poseen actividad antitumoral
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
ATE472551T1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
MX9307011A (es) Derivados hidrosolubles de camptotecina, proceso para su preparacion y composiciones farmaceuticas que los contienen.
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
EA200200922A1 (ru) Композиция, включающая камптотецин и производное пиримидина, для лечения рака
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
ATE217531T1 (de) Verwendung von natriumchlorid zur verminderung der gastrointestinalen toxizität von camptotecinderivaten.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
SE9803107D0 (sv) Novel Compunds
AR035988A1 (es) Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento
SE9803277D0 (sv) Novel compounds
DE60143020D1 (de) 9-alkylamino-1-nitroacridin-derivate